|View printer-friendly version|
|Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2009 on May 4, 2009|
|BOULDER, Colo., Apr 29, 2009 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for
the third quarter of fiscal 2009 on Monday, May 4, 2009, and will hold a
conference call on Tuesday, May 5, 2009 at 9:00 a.m. eastern time to
discuss these results. Robert E. Conway, Chief Executive Officer, and
Michael Carruthers, Chief Financial Officer, will lead the call.
Conference Call Information
A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 2844590.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at large market opportunities. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.